Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection

Sian E. Faustini, Sian E. Jossi, Marisol Perez-Toledo, Adrian M. Shields, Joel D. Allen, Yasunori Watanabe, Maddy L. Newby, Alex Cook, Carrie R Willcox, Mahboob Salim, Margaret Goodall, Jennifer L. Heaney, Edith Marcial-Juarez, Gabriella L. Morley, Barbara Torlinska, David C. Wraith, Tonny V. Veenith, Stephen Harding, Stephen Jolles, Mark J. Ponsford, Tim Plant, Aarnoud Huissoon, Matthew K. O’Shea, Benjamin E. Willcox, Mark T. Drayson, Max Crispin, Adam F. Cunningham, Alex G. Richter
doi: https://doi.org/10.1101/2020.06.16.20133025
Sian E. Faustini
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sian E. Jossi
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisol Perez-Toledo
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian M. Shields
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel D. Allen
2School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasunori Watanabe
2School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, U.K.
3Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maddy L. Newby
2School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Cook
4Binding Site Group Ltd, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie R Willcox
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahboob Salim
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Goodall
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Heaney
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edith Marcial-Juarez
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriella L. Morley
5Institute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Torlinska
6Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Wraith
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tonny V. Veenith
7Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, B15 2TH, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Harding
4Binding Site Group Ltd, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Jolles
8Immunodeficiency Centre for Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Ponsford
8Immunodeficiency Centre for Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Plant
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aarnoud Huissoon
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
9Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew K. O’Shea
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin E. Willcox
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark T. Drayson
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max Crispin
2School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam F. Cunningham
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex G. Richter
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.g.richter@bham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Detecting antibody responses during and after SARS-CoV-2 infection is essential in determining the seroepidemiology of the virus and the potential role of antibody in disease. Scalable, sensitive and specific serological assays are essential to this process. The detection of antibody in hospitalized patients with severe disease has proven straightforward; detecting responses in subjects with mild disease and asymptomatic infections has proven less reliable. We hypothesized that the suboptimal sensitivity of antibody assays and the compartmentalization of the antibody response may contribute to this effect.

Methods We systemically developed an ELISA assay, optimising different antigens and amplification steps, in serum and saliva from symptomatic and asymptomatic SARS-CoV-2-infected subjects.

Results Using trimeric spike glycoprotein, rather than nucleocapsid enabled detection of responses in individuals with low antibody responses. IgG1 and IgG3 predominate to both antigens, but more anti-spike IgG1 than IgG3 was detectable. All antigens were effective for detecting responses in hospitalized patients. Anti-spike, but not nucleocapsid, IgG, IgA and IgM antibody responses were readily detectable in saliva from non-hospitalized symptomatic and asymptomatic individuals. Antibody responses in saliva and serum were largely independent of each other and symptom reporting.

Conclusions Detecting antibody responses in both saliva and serum is optimal for determining virus exposure and understanding immune responses after SARS-CoV-2 infection.

Funding This work was funded by the University of Birmingham, the National Institute for Health Research (UK), the NIH National Institute for Allergy and Infectious Diseases, the Bill and Melinda Gates Foundation and the University of Southampton.

Competing Interest Statement

AC and SH are employed by the Binding Site Group Ltd. AH has a commercial relationship with Binding Site Group Ltd. MTD and MG have a commercial relationship with Abingdon Health. The rest of the authors declared no conflict of interest.

Funding Statement

AFC is grateful for funding from The Medical Research Council, The Institute for Global Innovation and The University of Birmingham for funding. This study was supported by the UK National Institute for Health Research, Birmingham Biomedical Research Centres Funding scheme. The work in Prof. Max Crispin's laboratory was funded by the International AIDS Vaccine Initiative, Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (OPP1196345/INV-008813, OPP1084519 and OPP1115782), the Scripps Consortium for HIV Vaccine Development (CHAVD) (NIH: National Institute for Allergy and Infectious Diseases AI144462), and the University of Southampton Coronavirus Response Fund. The CoCo study was funded internally by the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust and carried out at the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the London - Camden & Kings Cross Research Ethics Committee (reference 20/HRA/1817), and the University of Birmingham (reference ERN_16-178).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available upon reasonable request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E. Faustini, Sian E. Jossi, Marisol Perez-Toledo, Adrian M. Shields, Joel D. Allen, Yasunori Watanabe, Maddy L. Newby, Alex Cook, Carrie R Willcox, Mahboob Salim, Margaret Goodall, Jennifer L. Heaney, Edith Marcial-Juarez, Gabriella L. Morley, Barbara Torlinska, David C. Wraith, Tonny V. Veenith, Stephen Harding, Stephen Jolles, Mark J. Ponsford, Tim Plant, Aarnoud Huissoon, Matthew K. O’Shea, Benjamin E. Willcox, Mark T. Drayson, Max Crispin, Adam F. Cunningham, Alex G. Richter
medRxiv 2020.06.16.20133025; doi: https://doi.org/10.1101/2020.06.16.20133025
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E. Faustini, Sian E. Jossi, Marisol Perez-Toledo, Adrian M. Shields, Joel D. Allen, Yasunori Watanabe, Maddy L. Newby, Alex Cook, Carrie R Willcox, Mahboob Salim, Margaret Goodall, Jennifer L. Heaney, Edith Marcial-Juarez, Gabriella L. Morley, Barbara Torlinska, David C. Wraith, Tonny V. Veenith, Stephen Harding, Stephen Jolles, Mark J. Ponsford, Tim Plant, Aarnoud Huissoon, Matthew K. O’Shea, Benjamin E. Willcox, Mark T. Drayson, Max Crispin, Adam F. Cunningham, Alex G. Richter
medRxiv 2020.06.16.20133025; doi: https://doi.org/10.1101/2020.06.16.20133025

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)